Skip to content
10-Q

Quarterly Report

ARCUTIS BIOTHERAPEUTICS, INC. ARQT

0001787306-25-000144

← back to feed
Filed
Oct 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 22, 2025 122.49M sh
Shares Diluted Q3 2025 · Sep 30, 2025 132.88M sh
Shares Diluted Q3 2025 · Sep 30, 2025 126.89M sh
Shares Diluted Q3 2025 · Sep 30, 2024 124.3M sh
Shares Diluted Q3 2025 · Sep 30, 2024 119.63M sh
Capex Q3 2025 · Sep 30, 2025 $686K
Capex Q3 2025 · Sep 30, 2024 $143K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$31.81M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$111.41M
Long Term Debt Q3 2025 · Sep 30, 2025 $107.5M
Long Term Debt Q3 2025 · Dec 31, 2024 $107.2M
Short Term Debt Q3 2025 · Sep 30, 2025 $1M
Short Term Debt Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $47.12M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $71.34M
Stockholders Equity Q3 2025 · Sep 30, 2025 $158.07M
Stockholders Equity Q3 2025 · Jun 30, 2025 $138.97M
Stockholders Equity Q3 2025 · Mar 31, 2025 $142.66M
Stockholders Equity Q3 2025 · Dec 31, 2024 $157.54M
Stockholders Equity Q3 2025 · Sep 30, 2024 $156.64M
Stockholders Equity Q3 2025 · Jun 30, 2024 $186.43M
Stockholders Equity Q3 2025 · Mar 31, 2024 $224.94M
Stockholders Equity Q3 2025 · Dec 31, 2023 $88.67M
Current Liabilities Q3 2025 · Sep 30, 2025 $99.77M
Current Liabilities Q3 2025 · Dec 31, 2024 $81.01M
Total Liabilities Q3 2025 · Sep 30, 2025 $212.9M
Total Liabilities Q3 2025 · Dec 31, 2024 $191.35M
Current Assets Q3 2025 · Sep 30, 2025 $349.22M
Current Assets Q3 2025 · Dec 31, 2024 $335.82M
Total Assets Q3 2025 · Sep 30, 2025 $370.98M
Total Assets Q3 2025 · Dec 31, 2024 $348.89M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.06
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.26
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.33
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.08
Eps Basic Q3 2025 · Sep 30, 2025 $0.06
Eps Basic Q3 2025 · Sep 30, 2025 −$0.26
Eps Basic Q3 2025 · Sep 30, 2024 −$0.33
Eps Basic Q3 2025 · Sep 30, 2024 −$1.08
Sga Expense Q3 2025 · Sep 30, 2025 $62.4M
Sga Expense Q3 2025 · Sep 30, 2025 $195.58M
Sga Expense Q3 2025 · Sep 30, 2024 $58.82M
Sga Expense Q3 2025 · Sep 30, 2024 $171.78M
Rd Expense Q3 2025 · Sep 30, 2025 $19.6M
Rd Expense Q3 2025 · Sep 30, 2025 $56.6M
Rd Expense Q3 2025 · Sep 30, 2024 $19.5M
Rd Expense Q3 2025 · Sep 30, 2024 $61.94M
Net Income Q3 2025 · Sep 30, 2025 $7.41M
Net Income Q3 2025 · Sep 30, 2025 −$33.54M
Net Income Q3 2025 · Jun 30, 2025 −$15.89M
Net Income Q3 2025 · Mar 31, 2025 −$25.06M
Net Income Q3 2025 · Sep 30, 2024 −$41.54M
Net Income Q3 2025 · Sep 30, 2024 −$129.25M
Net Income Q3 2025 · Jun 30, 2024 −$52.33M
Net Income Q3 2025 · Mar 31, 2024 −$35.38M
Operating Income Q3 2025 · Sep 30, 2025 $8.53M
Operating Income Q3 2025 · Sep 30, 2025 −$30.61M
Operating Income Q3 2025 · Sep 30, 2024 −$39.07M
Operating Income Q3 2025 · Sep 30, 2024 −$120.77M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $8.69M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $25.01M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $5.5M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $12.22M
Revenue Q3 2025 · Sep 30, 2025 $99.22M
Revenue Q3 2025 · Sep 30, 2025 $246.57M
Revenue Q3 2025 · Sep 30, 2024 $44.76M
Revenue Q3 2025 · Sep 30, 2024 $125.18M